NAT2 and lung carcinoma: Gong et al., (2001) in addition to a meta-analysis of prostate cancer, disagree with studies undertaken on solid tumors in adults which demonstrate that NAT2 slow acetylator individuals are at a greater risk of prostate and lung cancer (Koda et al., 2017; Liu et al., 2015).